<DOC>
	<DOCNO>NCT03025945</DOCNO>
	<brief_summary>Prospective , randomize , double-masked , placebo-controlled clinical study define effective use topical non-steroidal anti-inflammatory drug add topical steroid use uncomplicated phacoemulsification prevention pseudophakic cystoid macular edema .</brief_summary>
	<brief_title>Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3 % Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<criteria>Subjects , 18 old subject visually significant cataract undergo phacoemulsification implantation intracapsular position intraocular lens . previous uveitis ( &lt; 1 year ) previous anterior segment intraocular surgery hypersensitivity allergy NSAIDs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>